Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study
ConclusionsThe results of this study demonstrate an association between DDP-4i use and reduced mortality in people with T2DM who tested PCR positive for COVID-19.
Source: Diabetes Therapy - Category: Endocrinology Source Type: research
More News: COVID-19 | CT Scan | Databases & Libraries | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Insulin | Intensive Care | Obesity | Study | Turkey Health